title: Tumor initiating cells in pancreatic cancer: A critical view.
abstract: Emerging evidence points to the existence of pancreatic cancer stem cells (CSC) as the culprit in the initiation, maintenance, metastasis, and treatment resistance of pancreatic cancer. The existence of such a cell population would have an important impact on the design of novel therapies against this devastating disease. However, no in vivo validation or rebuttal of the pancreatic CSC hypothesis exists. Major backlashes in the discussion on CSC are firstly, the confusion between the terms CSC and cell of origin of pancreatic ductal adenocarcinoma (PDAC), secondly the ambiguity of the cell of origin itself and thirdly, the fact that the CSC hypothesis is based on cell sorting and xenografting experiments; the latter of which often precludes solid conclusions because of the lack of a natural microenvironment and differences in drug delivery. Nonetheless, recent studies in other cancers partially support the CSC hypothesis by demonstrating a link between epithelial-to-mesenchymal transdifferentiation/transition (EMT) and CSC properties. Such a link is again open to dispute as EMT is a reversible process which is highly dependent on major oncogenic pathways in PDAC [e.g. K-Ras, transforming growth factor-β (TGF-β)] rather than on presumed cancer stem cell pathways. Hence, the available evidence does not robustly support the CSC concept in PDAC and a thorough validation of this hypothesis in well-defined genetically engineered mouse models of pancreatic cancer is required.
authors: Bo Kong, Christoph W Michalski, Jörg Kleeff, Department of Surgery, Technische Universität München, Ismaningerstrasse 22, 81675 Munich, Germany.
authors: Bo
authors: B
authors: Kong
authors: Christoph W
authors: CW
authors: Michalski
authors: Jörg
authors: J
authors: Kleeff
references: Cancer Cell. 2009 Jun 2;15(6):489-500
references: 19477428
references: Cell. 2008 May 16;133(4):704-15
references: 18485877
references: Am J Pathol. 2006 Dec;169(6):2223-35
references: 17148683
references: Biochim Biophys Acta. 2009 Apr;1792(4):248-59
references: 19233264
references: Annu Rev Biochem. 1990;59:783-836
references: 1695833
references: Cancer Res. 2007 Feb 15;67(4):1563-70
references: 17308095
references: Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18907-12
references: 19028876
references: Science. 2007 Jul 20;317(5836):337
references: 17641192
references: Cancer Cell. 2006 Oct;10(4):257-68
references: 17045204
references: Gastroenterology. 2007 Apr;132(4):1447-64
references: 17408641
references: Cancer Cell. 2005 Sep;8(3):185-95
references: 16169464
references: Ann Surg Oncol. 2007 Dec;14(12):3629-37
references: 17909916
references: Nature. 1994 Feb 17;367(6464):645-8
references: 7509044
references: J Cell Biochem. 2009 May 1;107(1):40-5
references: 19301275
references: Science. 2009 Jun 12;324(5933):1457-61
references: 19460966
references: Cancer Res. 2008 Jun 1;68(11):4018-21
references: 18519656
references: Cancer Res. 2009 Mar 15;69(6):2400-7
references: 19276344
references: Cancer Cell. 2007 Mar;11(3):291-302
references: 17349585
references: Cell Stem Cell. 2007 Sep 13;1(3):313-23
references: 18371365
references: Int J Cancer. 2007 Aug 15;121(4):699-705
references: 17534898
references: Pancreas. 2007 Oct;35(3):212-7
references: 17895840
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: Mol Cells. 2008 Nov 30;26(5):514-6
references: 18711315
references: Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18913-8
references: 19028870
references: Cancer Res. 2007 Feb 1;67(3):1030-7
references: 17283135
references: Gastroenterology. 2009 Sep;137(3):1102-13
references: 19501590